Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia

Idiopathic pulmonary fibrosis is pathologically represented by usual interstitial pneumonia (UIP). Conventional bleomycin models used to study pathogenic mechanisms of pulmonary fibrosis display transient inflammation and fibrosis, so their relevance to UIP is limited. We developed a novel chronic i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Life science alliance 2022-01, Vol.5 (1), p.e202101059
Hauptverfasser: Miura, Yoko, Lam, Maggie, Bourke, Jane E, Kanazawa, Satoshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page e202101059
container_title Life science alliance
container_volume 5
creator Miura, Yoko
Lam, Maggie
Bourke, Jane E
Kanazawa, Satoshi
description Idiopathic pulmonary fibrosis is pathologically represented by usual interstitial pneumonia (UIP). Conventional bleomycin models used to study pathogenic mechanisms of pulmonary fibrosis display transient inflammation and fibrosis, so their relevance to UIP is limited. We developed a novel chronic induced-UIP (iUIP) model, inducing fibrosis in D1CC×D1BC transgenic mice by intra-tracheal instillation of bleomycin mixed with microbubbles followed by sonoporation (BMS). A bimodal fibrotic lung disease was observed over 14 wk, with an acute phase similar to nonspecific interstitial pneumonia (NSIP), followed by partial remission and a chronic fibrotic phase with honeycombing similar to UIP. In this secondary phase, we observed poor vascularization despite elevated PDGFRβ expression. γ2PF- and MMP7-positive epithelial cells, consistent with an invasive phenotype, were predominantly adjacent to fibrotic areas. Most invasive cells were and/or positive. This iUIP mouse model displays key features of idiopathic pulmonary fibrosis and has identified potential mechanisms contributing to the onset of NSIP and progression to UIP. The model will provide a useful tool for the assessment of therapeutic interventions to oppose acute and chronic fibrosis.
doi_str_mv 10.26508/lsa.202101059
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8572746</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>34728556</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-976f1ceee8fea0fd9d792033967e1e705739cf3217d8ab43e91839b9894954ab3</originalsourceid><addsrcrecordid>eNpVkEtLxDAQx4Mo7rLu1aP0C3TNs2kugi6-YMGLHjyFtJlopE2Wpl3Yb2_wsSgM82Dm_x_4IXRO8IpWAteXXTIriinBBAt1hOZUSFESLOXxn36Glil9YIxpDi74KZoxLmktRDVHrze-j9Z0hfPNEJNPhQ-FKULcQVf0cUqQs819dEXTQez3rQ-lD3ZqwRZTmrLUhxGGNPrR52EbYOpj8OYMnTjTJVj-1AV6ubt9Xj-Um6f7x_X1pmy5qMZSycqRFgBqBwY7q6xUFDOmKgkEJBaSqdYxSqStTcMZKFIz1ahacSW4adgCXX37bqemB9tCGAfT6e3gezPsdTRe_98E_67f4k7XQlLJq2yw-jZoM4A0gDtoCdZfnHXmrA-cs-Di78fD-S9V9gnuU3tb</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Miura, Yoko ; Lam, Maggie ; Bourke, Jane E ; Kanazawa, Satoshi</creator><creatorcontrib>Miura, Yoko ; Lam, Maggie ; Bourke, Jane E ; Kanazawa, Satoshi</creatorcontrib><description>Idiopathic pulmonary fibrosis is pathologically represented by usual interstitial pneumonia (UIP). Conventional bleomycin models used to study pathogenic mechanisms of pulmonary fibrosis display transient inflammation and fibrosis, so their relevance to UIP is limited. We developed a novel chronic induced-UIP (iUIP) model, inducing fibrosis in D1CC×D1BC transgenic mice by intra-tracheal instillation of bleomycin mixed with microbubbles followed by sonoporation (BMS). A bimodal fibrotic lung disease was observed over 14 wk, with an acute phase similar to nonspecific interstitial pneumonia (NSIP), followed by partial remission and a chronic fibrotic phase with honeycombing similar to UIP. In this secondary phase, we observed poor vascularization despite elevated PDGFRβ expression. γ2PF- and MMP7-positive epithelial cells, consistent with an invasive phenotype, were predominantly adjacent to fibrotic areas. Most invasive cells were and/or positive. This iUIP mouse model displays key features of idiopathic pulmonary fibrosis and has identified potential mechanisms contributing to the onset of NSIP and progression to UIP. The model will provide a useful tool for the assessment of therapeutic interventions to oppose acute and chronic fibrosis.</description><identifier>ISSN: 2575-1077</identifier><identifier>EISSN: 2575-1077</identifier><identifier>DOI: 10.26508/lsa.202101059</identifier><identifier>PMID: 34728556</identifier><language>eng</language><publisher>United States: Life Science Alliance LLC</publisher><subject>Animals ; Biomarkers ; Biopsy ; Bleomycin - adverse effects ; Disease Models, Animal ; Disease Progression ; Disease Susceptibility ; DNA Damage ; Epithelial Cells - metabolism ; Epithelial Cells - pathology ; Fluorescent Antibody Technique ; Idiopathic Interstitial Pneumonias - etiology ; Idiopathic Interstitial Pneumonias - metabolism ; Idiopathic Interstitial Pneumonias - pathology ; Idiopathic Pulmonary Fibrosis - etiology ; Idiopathic Pulmonary Fibrosis - metabolism ; Idiopathic Pulmonary Fibrosis - pathology ; Immunohistochemistry ; Mice ; Mice, Transgenic</subject><ispartof>Life science alliance, 2022-01, Vol.5 (1), p.e202101059</ispartof><rights>2021 Miura et al.</rights><rights>2021 Miura et al. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-976f1ceee8fea0fd9d792033967e1e705739cf3217d8ab43e91839b9894954ab3</citedby><cites>FETCH-LOGICAL-c456t-976f1ceee8fea0fd9d792033967e1e705739cf3217d8ab43e91839b9894954ab3</cites><orcidid>0000-0003-0690-0993 ; 0000-0001-7314-9234</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572746/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572746/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34728556$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miura, Yoko</creatorcontrib><creatorcontrib>Lam, Maggie</creatorcontrib><creatorcontrib>Bourke, Jane E</creatorcontrib><creatorcontrib>Kanazawa, Satoshi</creatorcontrib><title>Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia</title><title>Life science alliance</title><addtitle>Life Sci Alliance</addtitle><description>Idiopathic pulmonary fibrosis is pathologically represented by usual interstitial pneumonia (UIP). Conventional bleomycin models used to study pathogenic mechanisms of pulmonary fibrosis display transient inflammation and fibrosis, so their relevance to UIP is limited. We developed a novel chronic induced-UIP (iUIP) model, inducing fibrosis in D1CC×D1BC transgenic mice by intra-tracheal instillation of bleomycin mixed with microbubbles followed by sonoporation (BMS). A bimodal fibrotic lung disease was observed over 14 wk, with an acute phase similar to nonspecific interstitial pneumonia (NSIP), followed by partial remission and a chronic fibrotic phase with honeycombing similar to UIP. In this secondary phase, we observed poor vascularization despite elevated PDGFRβ expression. γ2PF- and MMP7-positive epithelial cells, consistent with an invasive phenotype, were predominantly adjacent to fibrotic areas. Most invasive cells were and/or positive. This iUIP mouse model displays key features of idiopathic pulmonary fibrosis and has identified potential mechanisms contributing to the onset of NSIP and progression to UIP. The model will provide a useful tool for the assessment of therapeutic interventions to oppose acute and chronic fibrosis.</description><subject>Animals</subject><subject>Biomarkers</subject><subject>Biopsy</subject><subject>Bleomycin - adverse effects</subject><subject>Disease Models, Animal</subject><subject>Disease Progression</subject><subject>Disease Susceptibility</subject><subject>DNA Damage</subject><subject>Epithelial Cells - metabolism</subject><subject>Epithelial Cells - pathology</subject><subject>Fluorescent Antibody Technique</subject><subject>Idiopathic Interstitial Pneumonias - etiology</subject><subject>Idiopathic Interstitial Pneumonias - metabolism</subject><subject>Idiopathic Interstitial Pneumonias - pathology</subject><subject>Idiopathic Pulmonary Fibrosis - etiology</subject><subject>Idiopathic Pulmonary Fibrosis - metabolism</subject><subject>Idiopathic Pulmonary Fibrosis - pathology</subject><subject>Immunohistochemistry</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><issn>2575-1077</issn><issn>2575-1077</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkEtLxDAQx4Mo7rLu1aP0C3TNs2kugi6-YMGLHjyFtJlopE2Wpl3Yb2_wsSgM82Dm_x_4IXRO8IpWAteXXTIriinBBAt1hOZUSFESLOXxn36Glil9YIxpDi74KZoxLmktRDVHrze-j9Z0hfPNEJNPhQ-FKULcQVf0cUqQs819dEXTQez3rQ-lD3ZqwRZTmrLUhxGGNPrR52EbYOpj8OYMnTjTJVj-1AV6ubt9Xj-Um6f7x_X1pmy5qMZSycqRFgBqBwY7q6xUFDOmKgkEJBaSqdYxSqStTcMZKFIz1ahacSW4adgCXX37bqemB9tCGAfT6e3gezPsdTRe_98E_67f4k7XQlLJq2yw-jZoM4A0gDtoCdZfnHXmrA-cs-Di78fD-S9V9gnuU3tb</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Miura, Yoko</creator><creator>Lam, Maggie</creator><creator>Bourke, Jane E</creator><creator>Kanazawa, Satoshi</creator><general>Life Science Alliance LLC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0690-0993</orcidid><orcidid>https://orcid.org/0000-0001-7314-9234</orcidid></search><sort><creationdate>20220101</creationdate><title>Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia</title><author>Miura, Yoko ; Lam, Maggie ; Bourke, Jane E ; Kanazawa, Satoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-976f1ceee8fea0fd9d792033967e1e705739cf3217d8ab43e91839b9894954ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Biomarkers</topic><topic>Biopsy</topic><topic>Bleomycin - adverse effects</topic><topic>Disease Models, Animal</topic><topic>Disease Progression</topic><topic>Disease Susceptibility</topic><topic>DNA Damage</topic><topic>Epithelial Cells - metabolism</topic><topic>Epithelial Cells - pathology</topic><topic>Fluorescent Antibody Technique</topic><topic>Idiopathic Interstitial Pneumonias - etiology</topic><topic>Idiopathic Interstitial Pneumonias - metabolism</topic><topic>Idiopathic Interstitial Pneumonias - pathology</topic><topic>Idiopathic Pulmonary Fibrosis - etiology</topic><topic>Idiopathic Pulmonary Fibrosis - metabolism</topic><topic>Idiopathic Pulmonary Fibrosis - pathology</topic><topic>Immunohistochemistry</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miura, Yoko</creatorcontrib><creatorcontrib>Lam, Maggie</creatorcontrib><creatorcontrib>Bourke, Jane E</creatorcontrib><creatorcontrib>Kanazawa, Satoshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Life science alliance</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miura, Yoko</au><au>Lam, Maggie</au><au>Bourke, Jane E</au><au>Kanazawa, Satoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia</atitle><jtitle>Life science alliance</jtitle><addtitle>Life Sci Alliance</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>5</volume><issue>1</issue><spage>e202101059</spage><pages>e202101059-</pages><issn>2575-1077</issn><eissn>2575-1077</eissn><abstract>Idiopathic pulmonary fibrosis is pathologically represented by usual interstitial pneumonia (UIP). Conventional bleomycin models used to study pathogenic mechanisms of pulmonary fibrosis display transient inflammation and fibrosis, so their relevance to UIP is limited. We developed a novel chronic induced-UIP (iUIP) model, inducing fibrosis in D1CC×D1BC transgenic mice by intra-tracheal instillation of bleomycin mixed with microbubbles followed by sonoporation (BMS). A bimodal fibrotic lung disease was observed over 14 wk, with an acute phase similar to nonspecific interstitial pneumonia (NSIP), followed by partial remission and a chronic fibrotic phase with honeycombing similar to UIP. In this secondary phase, we observed poor vascularization despite elevated PDGFRβ expression. γ2PF- and MMP7-positive epithelial cells, consistent with an invasive phenotype, were predominantly adjacent to fibrotic areas. Most invasive cells were and/or positive. This iUIP mouse model displays key features of idiopathic pulmonary fibrosis and has identified potential mechanisms contributing to the onset of NSIP and progression to UIP. The model will provide a useful tool for the assessment of therapeutic interventions to oppose acute and chronic fibrosis.</abstract><cop>United States</cop><pub>Life Science Alliance LLC</pub><pmid>34728556</pmid><doi>10.26508/lsa.202101059</doi><orcidid>https://orcid.org/0000-0003-0690-0993</orcidid><orcidid>https://orcid.org/0000-0001-7314-9234</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2575-1077
ispartof Life science alliance, 2022-01, Vol.5 (1), p.e202101059
issn 2575-1077
2575-1077
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8572746
source MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Animals
Biomarkers
Biopsy
Bleomycin - adverse effects
Disease Models, Animal
Disease Progression
Disease Susceptibility
DNA Damage
Epithelial Cells - metabolism
Epithelial Cells - pathology
Fluorescent Antibody Technique
Idiopathic Interstitial Pneumonias - etiology
Idiopathic Interstitial Pneumonias - metabolism
Idiopathic Interstitial Pneumonias - pathology
Idiopathic Pulmonary Fibrosis - etiology
Idiopathic Pulmonary Fibrosis - metabolism
Idiopathic Pulmonary Fibrosis - pathology
Immunohistochemistry
Mice
Mice, Transgenic
title Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T10%3A48%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bimodal%20fibrosis%20in%20a%20novel%20mouse%20model%20of%20bleomycin-induced%20usual%20interstitial%20pneumonia&rft.jtitle=Life%20science%20alliance&rft.au=Miura,%20Yoko&rft.date=2022-01-01&rft.volume=5&rft.issue=1&rft.spage=e202101059&rft.pages=e202101059-&rft.issn=2575-1077&rft.eissn=2575-1077&rft_id=info:doi/10.26508/lsa.202101059&rft_dat=%3Cpubmed_cross%3E34728556%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34728556&rfr_iscdi=true